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PURPOSE. Infantile nystagmus syndrome (INS) is often associated with abnormalities of axonal
outgrowth and connectivity. To determine if this manifests in extraocular muscle innervation,
specimens from children with idiopathic INS or INS and albinism were examined and
compared to normal age-matched control extraocular muscles.
METHODS. Extraocular muscles removed during normal surgery on children with idiopathic
INS or INS and albinism were immunostained for neuromuscular junctions, myofiber type, the
immature form of the acetylcholine receptor, and brain-derived neurotrophic factor (BDNF)
and compared to age-matched controls.
RESULTS. Muscles from both the idiopathic INS and INS and albinism groups had
neuromuscular junctions that were 35% to 71% smaller based on myofiber area and myofiber
perimeter than found in age-matched controls, and this was seen on both fast and slow
myosin heavy chain isoform–expressing myofibers (all P < 0.015). Muscles from subjects with
INS and albinism showed a 7-fold increase in neuromuscular junction numbers on fast
myofibers expressing the immature gamma subunit of the acetylcholine receptor. The
extraocular muscles from both INS subgroups showed a significant increase in the number
and size of slow myofibers compared to age-matched controls. Brain-derived neurotrophic
factor was expressed in control muscle but was virtually absent in the INS muscles.
CONCLUSIONS. These studies suggest that, relative to the final common pathway, INS is not the
same between different patient etiologies. It should be possible to modulate these final
common pathway abnormalities, via exogenous application of appropriate drugs, with the
hope that this type of treatment may reduce the involuntary oscillatory movements in these
children.
Keywords: nystagmus, neuromuscular junction, albinism, acetylcholine receptor, extraocular
muscles
Infantile nystagmus syndrome (INS) is an eye movementdisorder characterized by conjugate, involuntary oscillations
of the eyes that can result in substantially decreased visual
acuity for most patients. Despite a prevalence of 0.03% to
0.24% in the population,1,2 there currently is no effective cure
for this visually debilitating disorder.3 Often diagnosed in the
first 2 to 3 months of life, a large proportion of INS patients
have no known contributing factor for their gaze holding
disorder (idiopathic INS; 2.9 per 10,000 people under age 18).2
However, INS is commonly associated with afferent visual
defects including bilateral optic nerve hypoplasia, aniridia,
achiasma, retinal dystrophies, and albinism.4 Albinism in
particular has a strong association with INS, with approximate-
ly 90% of individuals with albinism also having nystagmus
(88%5; 89.9%6; 89%7).5–7 Even patients with albinism and no
clinically detectable nystagmus were shown to have significant
saccadic instabilities.8 While there are a number of genes
associated with different forms of albinism, the lack of
pigmentation in these individuals leads to foveal hypoplasia
and abnormal routing of the optic nerves.9,10 In addition, it has
been shown in animal models of albinism that the optic nerves
contain a population of abnormal axons.11 Thus, lack of
melanin has been described as a primary cause of the resultant
nystagmus and reduced visual acuity common to albinism.12
There is other evidence that abnormalities in axonal outgrowth
during development play a critical role in development of
idiopathic INS. Recent work has shown that approximately 25%
of children with idiopathic INS have a mutation in the FRMD7
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gene,13 which functions in controlling nerve outgrowth.14 The
linkage between albinism and nystagmus is further strength-
ened by the demonstration that albino mice and rabbits also
have nystagmus-like eye movements.15,16
There are currently very few treatments for reducing the
involuntary oscillatory movements associated with INS.17 Most
drug treatments involve systemic delivery of gamma amino-
butyric acid (GABA) agonists and potassium channel blockers,
as well as a variety of other drugs; these treatments often have
unwanted systemic side effects.18 The two main surgical
procedures performed on the extraocular muscles for INS may
improve head posture and alter the nystagmus waveform but
do not eliminate the abnormal eye oscillations. The primary
goal of the Kestenbaum-Anderson surgical procedure19,20 is to
improve head posture by moving the null point, defined as the
eye position where the nystagmus intensity is the least and
vision is the best, into primary gaze. This surgery involves large
resections of selected extraocular muscles and recessions of
their antagonists. The muscles produced as surgical waste from
this procedure were the primary source of material examined
in the present study. Tenotomy surgery also does not eliminate
oscillatory movements.21 These approaches focus on the
symptoms, often the anomalous head posture, rather than a
potential ‘‘cure.’’ Development of more effective treatments
for nystagmus is significantly hampered by our lack of
understanding of the primary cause of the involuntary
oscillatory movements in a number of types of childhood-
onset nystagmus.
In a previous study, we demonstrated that the extraocular
muscles (EOMs) from idiopathic INS patients contained
centrally nucleated myofibers, a sign of denervation/reinner-
vation, as well as decreased density of innervating nerve fibers
and neuromuscular junctions (NMJ).22 Our goal in the present
study was to determine if similar findings would be seen in the
EOMs from patients with albinism and INS. Our original study
of EOM surgical waste specimens obtained from subjects with
idiopathic INS at the time of surgery suggested changes that
could reflect either retention of immature NMJ properties or a
process of escalated remodeling of the NMJ. To address this
second question, the overall NMJ length and area on both fast
and slow myofibers were determined. The expression patterns
of the immature gamma subunit on myofibers were assessed
morphometrically in both subjects with idiopathic INS and
subjects with INS associated with albinism, and these data
were compared to those derived from age-matched control
EOM samples. In addition, EOMs from all three groups of
subject were examined for expression of brain-derived
neurotrophic factor (BDNF).
METHODS
The EOM specimens from patients with INS, either idiopathic
or with associated albinism, were obtained as surgical waste at
the time of their regularly scheduled surgery, either at the
University of Minnesota Hospital or at the University Hospitals
of Leicester, National Health Service Trust. All research was
approved by the Institutional Review Board of each university
and complied with the tenets of the Declaration of Helsinki for
the use of human tissue in research. A diagnosis of albinism
was based on the presence of iris transillumination defects,
crossed asymmetry on visual evoked potential (VEP) record-
ings, and typical foveal hypoplasia on optical coherence
tomography (OCT) imaging. For idiopathic INS, the specimens
had typical eye movement recordings, normal OCTs, and
normal VEP and electroretinogram (ERG) examinations. All
specimens were given a unique number so that they were de-
identified, were embedded in tragacanth gum, and were frozen
in methylbutane chilled to a slurry on liquid nitrogen. Tissue
was stored at808C until sectioned. Patient demographics and
clinical characteristics are listed in the Table. Control
specimens were obtained from a variety of sources and have
been described in detail previously.23
All muscle samples were sectioned frozen at 10 lm.
Sections were stained for hematoxylin and eosin and used for
determination of mean myofiber cross-sectional area and
percent of myofibers with central nucleation. Tissue sections
were processed for the immunohistochemical visualization of
the slow myosin heavy chain isoform (MyHC) (1:1000;
Hybridoma Bank; University of Iowa, Iowa City, IA, USA),
neurofilament protein (smi-31; 1:30,000; BioLegend, Dedham,
MA, USA), and the gamma subunit of the acetylcholine
receptor (cAChR) (1:300; Abcam; Cambridge, MA, USA) using
our standard protocol, summarized here. Sections were rinsed
in 0.01 M phosphate-buffered saline (PBS) with 0.1% Triton X-
100 (antibody buffer), pH 7.4, blocked for 1 hour in the
appropriate serum at 10% in PBS, and incubated in primary
antibody diluted in antibody buffer overnight at 48C in humid
chambers. The sections were rinsed in PBS, followed by
incubation in a secondary antibody conjugated with either Cy3
(1:500; Jackson ImmunoResearch Laboratories; West Grove,
PA, USA) or Dylight 405 (1:100; Jackson ImmunoResearch
Laboratories) and diluted in antibody buffer. In addition,
selected sections were washed, followed by incubation with
a-bungarotoxin conjugated to Alexa Fluor 488 overnight.
Sections were washed and mounted with Vectashield (Vector
Laboratories, Burlingame, CA, USA).
Morphometric analyses were performed using either
Bioquant (Nashville, TN, USA) or ImageJ software (available
in the public domain at imagej.nih.gov/ij/). Myofiber mean
cross-sectional area and rate of central nucleation were
determined by manual tracing/counting on at least three
sections from different regions of the muscle specimen on a
minimum of 200 myofibers per slide. These were averaged for
each specimen and then averaged for all specimens in each of
the three groups. Neuromuscular junction density and length,
length relative to myofiber perimeter, and NMJ area compared
to myofiber area were determined on four or five specimens in
EOM from controls, subjects with idiopathic INS, and subjects
with INS and albinism. Perimeter was determined by manually
circling individual myofibers using length as the metric. Every
NMJ was characterized for each complete cross section, and at
least three slides were imaged and analyzed per muscle
specimen.
Within-subject comparisons were made between paired
muscles from the subjects with idiopathic INS and those with
INS and albinism; no significant difference was seen between
them, so data from a single subject were averaged for all
morphometric analyses.
In addition, the three groups of specimens were examined
for expression of BDNF using immunochemistry, with a sheep
anti-BDNF primary antibody (1:50, Abcam) and a donkey anti-
sheep Cy3 secondary antibody (1:200; Jackson ImmunoRe-
search Laboratories).
Data are reported as mean 6 standard error of the mean.
Statistical analyses were performed using ANOVA with a
Tukey’s post hoc multiple comparison test for multiple group
comparisons. Data were considered to be significantly different
if P < 0.05.
RESULTS
The EOM specimens from subjects with INS and albinism had
decreased myofiber cross-sectional areas, averaging 235.4 6
12.7 lm2 when all myofibers were included, compared to the
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specimens from control subjects and those with idiopathic
INS, averaging 348.5 6 21.22 and 378.4 6 70.72, respectively
(Fig. 1A). In addition, in both groups there was a significant
increase in numbers of myofibers with central nucleation, 12.9
6 2.3% for specimens from subjects with idiopathic INS and
16.18 6 2.88% for those with INS associated with albinism,
compared to normal age-matched control EOM, where only
1.28 6 0.27% of myofibers contained centralized nuclei (Fig.
1B).
When the EOM from subjects with idiopathic INS and INS
associated with albinism were examined, it appeared that the
NMJs were smaller than in the age-matched control specimens
(Fig. 2). Mean NMJ areas were calculated for EOM from both sets
of subjects as well as control muscles for myofibers expressing
either fast or slow MyHC (Figs. 3A, 3B). In the specimens from
individuals with idiopathic INS or INS associated with albinism,
the mean areas of the NMJs found on fast MyHC–positive
myofibers were 68.7% and 73.4%, respectively, significantly
different from the age-matched control values (Fig. 3A; both at P
¼ 0.0001). There were no significant differences between the
mean NMJ areas on slow myofibers in any of the three groups of
specimens (Fig. 3B). The decreased areas of NMJs correlated
with the measurements of nerve density (Fig. 3C). As shown
previously for specimens from subjects with idiopathic INS,22
the EOM from subjects with INS associated with albinism also
had significantly reduced nerve fiber density compared to
control values, at 0.39 6 0.1% compared to control values of
6.09 6 1.06% (Fig. 3C).
However, myofibers expressing slow and fast MyHC
isoforms are not uniform in cross-sectional area. To determine
if there was a difference relative to the size of slow compared
to fast myofibers, these values were recalculated based on NMJ
area relative to myofiber area and NMJ length relative to
myofiber perimeter (Fig. 4). This analysis showed that relative
to fiber size, whether perimeter or area, for both fast and slow
myofibers the NMJs were significantly smaller on the muscles
from the subjects with idiopathic INS and INS associated with
albinism than age-matched controls (Fig. 4). These differences
in NMJ size compared to age-matched control muscles were,
on average, between 62.5% and 71.3% smaller for fast
myofibers based on fiber area (P ¼ 0.007 for idiopathic INS
and P ¼ 0.0012 for INS associated with albinism) and 60%
smaller based on perimeter (P¼ 0.003 for idiopathic INS and P
¼ 0.0006 for INS associated with albinism) (Figs. 4A, 4C). For
the slow myofibers, the NMJs were, on average, 67% smaller
based on myofiber area (P¼ 0.0039 for idiopathic INS and P¼
0.0009 for INS associated with albinism), and 35% to 37%
smaller for slow myofibers based on fiber perimeter (P¼ 0.015
TABLE. Characteristics of the Subjects With Idiopathic INS and INS Associated With Albinism (INS/ALB)
Subject Sex
Age at
Surgery, y Diagnosis Nystagmus Type
1 F 7 Idiopathic INS Horizontal, right beating, left head turn
2 F 5 Idiopathic INS Horizontal, right head turn
3 M 6 Idiopathic INS Horizontal, left beating jerk, left head turn
4 M 10 Idiopathic INS Horizontal, left head turn
5 M 7 Idiopathic INS Horizontal, left beating jerk
6 M 3 Idiopathic INS Horizontal, left beating jerk nystagmus
7 M 8 Idiopathic INS Horizontal, left head turn
8 F 12 Idiopathic INS Horizontal, left head turn
9 F 18 Idiopathic INS Horizontal, left head turn
10 M 5 Idiopathic INS Horizontal, right beating
11 M 14 INS/ALB Horizontal, left head turn
12 M 2 INS/ALB Horizontal, left head turn
13 M 4 INS/ALB Horizontal, left head turn
14 M 3 INS/ALB Horizontal, left head turn
15 M 5 INS/ALB Horizontal, right head turn
16 F 5 INS/ALB Horizontal, left head turn
17 M 9 INS/ALB Horizontal, left head turn
18 M 5 INS/ALB Horizontal, left head turn
19 F 29 INS/ALB Horizontal, left head turn
20 M 22 INS/ALB Horizontal, left head turn
FIGURE 1. (A) Mean cross-sectional areas of EOM myofibers from control muscles compared to muscles from subjects with INS and albinism
compared to subjects with idiopathic INS. #Significant difference between INS and albinism compared to INS only. (B) Percent of myofibers with
central nucleation in the EOM from control muscles compared to EOM from subjects with INS and albinism compared to subjects with INS and no
known sensory afferent defects. *Significant difference from control. n ¼ 10 for all groups.
INS and Albinism and Neuromuscular Junctions IOVS j Month 2016 j Vol. 57 j No. 0 j 3
//titan/Production/i/iovs/live_jobs/iovs-57/iovs-57-04/iovs-57-04-18/layouts/iovs-57-04-18.3d  7 April 2016  6:58 pm  Allen Press, Inc.  Customer #IOVS-16-19129 Page 3
for idiopathic INS and P ¼ 0.009 for INS associated with
albinism) (Figs. 4B, 4D).
The small NMJs suggested that they might not be fully
mature or might be undergoing remodeling. To test this
hypothesis, the NMJs were examined for expression of the
immature cAChR, which is normally not expressed in the
NMJs of mature skeletal muscle. It should be noted that in
normal mature EOM, the NMJs on the majority of the slow
myofibers express the cAChR on the en grappe endings that
are commonly found on this fiber type.24,25 As expected, we
found many en grappe endings positive for the gamma
subunit on slow-positive myofibers as well as en plaque
endings on fast-positive myofibers that stained for a-bungaro-
toxin but appeared to be negative for the gamma subunit (Fig.
5A). In the EOM from subjects with INS associated with
albinism, fast myofibers with NMJs positive for the immature
gamma subunit were quite noticeable (Fig. 5B). Morphomet-
ric analysis of EOM from control, idiopathic INS, and INS
associated with albinism muscle specimens demonstrated a
significant 7-fold increase in the percent of fast myofibers
with gamma-positive NMJs in the EOM from subjects with INS
associated with albinism (Fig. 5C), from 2.23 6 0.2% to 15.67
6 3.4% compared to control subjects. While there was a 2-
fold increase, to 4.37 6 1.48%, in the percentage of fast fibers
with gamma-positive NMJs in the EOM of subjects with
idiopathic INS, this difference was not significantly different
from control. The percentage of fast fibers with gamma-
positive NMJs was also significantly different between the
EOM of subjects with INS associated with albinism and
idiopathic INS (Fig. 5C).
In the process of examining NMJs, it appeared that there
was a change in the proportions of fast and slow myofibers in
the EOM from subjects with INS associated with albinism
compared to controls (Figs. 6A, 6B). Quantification showed
that there was a significantly higher percentage of slow
myofibers in the EOM from the subjects with INS associated
with albinism compared to control, at 29.98 6 1.97%
compared to the control level of 15.04 6 1.8% (Fig. 6C). The
EOM from subjects with idiopathic nystagmus contained 27.53
6 2.82% slow-positive myofibers, which also was significantly
different from controls. When mean cross-sectional areas were
compared, the slow myofibers in specimens from subjects with
INS associated with albinism were significantly larger than
FIGURE 2. Neuromuscular junctions visualized with a-bungarotoxin conjugated to Alexa Fluor 488 in (A) an age-matched control EOM and (B) an
EOM from a subject with INS and albinism. Arrows indicate neuromuscular junctions. Scale bar: 50 lm.
FIGURE 3. Mean neuromuscular junction (NMJ) areas on (A) fast
myofibers, (B) slow myofibers, and (C) nerve density comparing
subjects with INS and albinism, subjects with idiopathic INS, and age-
matched controls. *Significant difference from control. n ¼ 4 for
controls, n ¼ 5 for idiopathic INS and INS and albinism specimens.
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FIGURE 4. (A) Mean neuromuscular junction (NMJ) area relative to fast myofiber area. (B) Mean NMJ area relative to slow myofiber area. (C) Mean
NMJ length relative to fast myofiber perimeter. (D) Mean NMJ length relative to slow myofiber perimeter. All comparisons are between subjects with
INS and albinism, subjects with idiopathic INS, and age-matched controls, *Significant difference from age-matched controls. n¼4 for controls, n¼5
for idiopathic INS and INS and albinism specimens.
FIGURE 5. (A) Photomicrograph of a control EOM immunostained with a-bungarotoxin bound to Alexa Fluor 488 (green), the gamma subunit of the
nicotinic acetylcholine receptor (red), and slow myosin heavy chain isoform (blue). (B) Photomicrograph of EOM from a subject with INS and
albinism immunostained as in (A). White arrows indicate neuromuscular junctions positive for both the gamma subunit and a-bungarotoxin on fast
myofibers. Yellow arrows indicate neuromuscular junctions that are positive for both the gamma subunit and a-bungarotoxin on slow fibers. The
purple arrow indicates a neuromuscular junction stained with a-bungarotoxin but negative for the gamma subunit. Bar is 20 lm. (C) Morphometric
analysis of the percentage of fast myofibers that had neuromuscular junctions positive for the immature gamma subunit of the nicotinic
acetylcholine receptor. *Significant difference from control. #Significant difference from idiopathic INS.
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control values, at 627.9 6 48.14 lm2 compared to 288.5 6
97.13 lm2 in control specimens (Fig. 6D). The mean cross-
sectional areas for the muscles from those with idiopathic INS
were 599.1 6 56.2 lm2. This was also significantly different
from control specimens.
All three cohorts of muscles were examined for expression
of BDNF (Fig. 7). Myofibers were positive for BDNF in all the
control muscles, with a relatively rare negative myofiber
interspersed between the largely positive myofiber population
(Fig. 7A). In contrast, the EOMs examined from the subjects
with idiopathic INS and INS and albinism were largely negative
for BDNF expression (Figs. 7B, 7C). In some of the specimens
from subjects with idiopathic INS, small numbers of BDNF-
positive myofibers could be seen (Fig. 7C, arrow), but these
were extremely rare in the specimens from the subjects with
INS and albinism.
DISCUSSION
The EOM from subjects with INS and albinism and idiopathic
INS were significantly different from the control specimens in a
number of ways. In the subjects with INS and albinism, these
differences included smaller NMJ compared to control EOM,
greater numbers of NMJ on fast myofibers expressing the
immature cAChR, a higher percentage of and larger slow
myofibers in these muscles, and the absence of BDNF-positive
myofibers. Similar differences were seen in the specimens from
subjects with idiopathic INS, except that there was only rare
expression of the immature acetylcholine receptor on fast
myofibers.
These results make sense in light of the broader context of
conditions with abnormal or aberrant nerve growth that often
coexist in children with idiopathic INS. The only gene thus far
FIGURE 6. (A) Photomicrograph of EOM from a control subject and (B) a subject with INS and albinism immunostained with a-bungarotoxin bound
to Alexa Fluor 488 (green), the gamma subunit of the nicotinic acetylcholine receptor (red), and slow myosin heavy chain isoform (MyHC) (blue).
Bar is 50 lm. (C) Morphometric analyses of the percent of myofibers positive for the slow MyHC in the EOM from all three cohorts. (D)
Morphometric analysis of the mean cross-sectional area of slow MyHC–positive myofibers in the EOM from all three cohorts. *Significant difference
from control. n ¼ 9 for all subject cohorts.
FIGURE 7. (A) Normal EOM immunostained for the expression of brain-derived neurotrophic factor (BDNF). Note that the majority of myofibers
were positive for BDNF, although negative myofibers were seen (arrow). (B) Representative section of an EOM from an INS/albinism subject
immunostained for BDNF. Note that the fibers shown are all negative in this field. (C) Representative section of an EOM from an idiopathic INS
subject immunostained for BDNF. Note that the fibers shown are all negative except the two indicated by the arrows. n¼ 9 for all subject cohorts.
Scale bar: 50 lm.
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associated with idiopathic INS is FRMD7,13 and a mutation in
this gene results in altered neurite outgrowth and develop-
ment.14,26 Similarly, albinism is associated with distinct
alterations to optic axon pathfinding from the retina to the
brain27 but there are also abnormal connections within other
systems including the auditory system.28 Another condition
associated with nystagmus is optic nerve hypoplasia, and a
number of studies have demonstrated that it is associated with
higher visual pathway abnormalities as well as developmental
abnormalities of midline brain structures and generalized white
matter hypoplasia.29,30 Infantile nystagmus syndrome is asso-
ciated with achiasma,31 which similarly to albinism represents
a miswiring in the pattern of optic axon projections to the
brain. The unresolved question is whether there are concom-
itant axon growth alterations in the motor output that controls
eye movements.
The oculomotor innervational status in subjects with
nystagmus associated with albinism has not been character-
ized. Two case reports demonstrated an association between
Duane’s syndrome, characterized by lack of innervation to the
lateral rectus muscle by the abducens nerve, and albinism.32.33
In our earlier study we showed that in the EOM from subjects
with idiopathic INS there was a significant reduction in the
density of NMJs that correlated with decreased density of
innervating nerve fibers.22 These studies suggest that there
may be a common mechanism in these patient populations
that affects the normal patterning of innervation.
In addition to an overall reduction in the density of
innervating motor axons, a significant decrease in the size of
NMJ and an increase in the number of NMJ on fast myofibers
that expressed the immature cAChRs were seen. While the
functional sequelae of these changes in innervational status in
these children were involuntary oscillatory movements of the
eyes, the mechanism causing these innervational changes in
altering eye stability is unclear. These innervational differences
may be a primary cause of the oscillatory movements, or may
be a secondary adaptation to the nystagmus. Nonetheless,
these differences would likely alter eye muscle function. The
literature on the role of neuromuscular maturation on muscle
function suggests that immature motor systems controlling
limb muscles are characterized by unstable temporal parame-
ters and dissociated firing patterns.34 In other studies where
experimental manipulations resulted in smaller NMJ, muscles
were weaker after either nerve or direct muscle stimulation
when compared to normal controls.35 Still other studies
showed decreased frequency of neurotransmitter release,36 as
well as both reduced synaptic efficiency and reduced force
generation.37,38 These could all play a role in producing
involuntary oscillatory eye movements.
The increase in the size and proportion of slow myofibers in
the EOM from the subjects with both INS and albinism and
idiopathic INS is very interesting. Fast and slow myofibers have
distinctly different contractile profiles, as slow myofibers
contract more slowly but produce more sustained force before
fatiguing.39 It is impossible to ascertain from single EOM
specimens whether this alteration in slow myosin–positive
myofibers is a primary or compensatory event in these children
with infantile nystagmus and albinism. If it is secondary, this
would suggest an attempt of the ocular motor system to drive
the EOM in these subjects toward a phenotype that could have
the potential to dampen the involuntary oscillatory eye
movements. Compensatory changes in myosin isoform expres-
sion are common after various types of perturbations of the
EOM. For example, significant alterations in fiber type densities
in the EOM were seen in animal models after various types of
treatments, including strabismus surgery40,41 or injection of
botulinum toxin A.42 Studies have shown a differential effect
on fast compared to slow myofibers after sustained treatment
with bone morphogenetic protein-4 (BMP-4)43 and an effect
only on slow myofibers after sustained treatment with BDNF.44
We are currently assessing if changes in slow myofiber number
and size are also found in albino animal models, and if so, we
should be able to test if modulation of these differences alters
the pattern of nystagmus found in these animals.
Interestingly, when endogenous expression of BDNF was
examined in control human muscles, it was preferentially
increased in the proximal and distal regions of the EOM and
essentially absent in the midbelly region of the muscle fibers.44
Differential expression of IGF-1 has also been demonstrated in
the EOM, but in a completely different pattern,45 suggesting a
tight regulation of neurotrophic expression patterning in the
maintenance of normal EOM structure and function. The
proximal and distal regions of the EOM contain mainly en
grappe NMJ that are more involved in the tonic or step phase
of muscle contraction.46 This geographic linkage in BDNF
localization suggests that BDNF could play a role in the
formation and/or maintenance of the en grappe synapses. The
relative absence of BDNF expression in the EOMs of both INS
groups compared to that seen in the control EOM is interesting
in light of the roles BDNF can play in neuromuscular structure
and function. Alterations of BDNF may be a precipitating factor
in the subjects with INS and albinism and in idiopathic INS.
This is supported by the demonstration that after experimental
abducens nerve section and application of only BDNF, only the
tonic firing component of abducens motor neuron behavior
returned.47 Thus, in its absence an increase in fast motor
neuron firing with decreased tonic firing would be predicted.
Further work is needed to clarify the role that the pattern of
BDNF expression and localization plays in EOM structure and
function in the EOM of both subjects with idiopathic INS and
those with INS and albinism.
In summary, we found that the EOM specimens from
subjects with INS and albinism differed from normal age-
matched controls in five distinct ways: decreased innervational
density, increased density of slow myofibers, increased size of
slow myofibers, decreased size of NMJs, and increased numbers
of fast fibers whose NMJs expressed the immature cAChR (Fig.
7). While EOM specimens from subjects with idiopathic INS also
showed decreased innervation and decreased size of NMJs, the
significant increase in immature synapses on fast myofibers was
unique to those specimens from the subjects with INS
associated with albinism. Specimens from subjects with INS
associated with optic nerve hypoplasia also did not show
increases in immature synapses on fast myofibers (McLoon LK,
et al. IOVS 2015;56:ARVO E-Abstract 3998). These studies
suggest that, relative to the final common pathway, INS is not
the same between different patient groups. It should be possible
to modulate these final common pathway abnormalities via
exogenous application of neurotrophic factors. Strategies might
include methods that alter the muscle contraction profile by
modification of myosin heavy isoform expression patterns such
as occurs with BMP-443 or BDNF,44 reducing insulin-like growth
factor levels with antibodies or binding proteins,48 or various
pharmacologic agents such as resveratrol, which have been
shown to produce a fast to slow myofiber type shift.49 If shown
to be effective in animal models of INS, one of these agents may
serve as a potential approach to reduce the involuntary
oscillatory movements in these children.
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